| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arnold-Chiari Malformation | 19 | 2020 | 43 | 5.680 |
Why?
|
| Hydrocephalus | 27 | 2022 | 105 | 4.620 |
Why?
|
| Cerebrospinal Fluid Shunts | 18 | 2022 | 53 | 3.210 |
Why?
|
| Decompression, Surgical | 11 | 2020 | 88 | 2.600 |
Why?
|
| Ventriculoperitoneal Shunt | 9 | 2020 | 24 | 1.590 |
Why?
|
| Equipment Failure | 10 | 2022 | 120 | 1.580 |
Why?
|
| Child | 60 | 2022 | 7233 | 1.520 |
Why?
|
| Poloxamer | 5 | 2007 | 29 | 1.190 |
Why?
|
| Cisterna Magna | 4 | 2022 | 11 | 1.180 |
Why?
|
| Ventriculostomy | 7 | 2020 | 29 | 1.180 |
Why?
|
| Cognition Disorders | 4 | 2016 | 234 | 1.170 |
Why?
|
| Craniotomy | 7 | 2018 | 89 | 1.140 |
Why?
|
| Electrodes, Implanted | 9 | 2020 | 184 | 1.060 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 242 | 1.050 |
Why?
|
| Surface-Active Agents | 5 | 2007 | 61 | 0.990 |
Why?
|
| Postoperative Complications | 15 | 2020 | 2299 | 0.980 |
Why?
|
| Skull Base | 2 | 2022 | 48 | 0.960 |
Why?
|
| Cerebral Hemorrhage | 5 | 2018 | 341 | 0.950 |
Why?
|
| Telemetry | 6 | 2004 | 36 | 0.930 |
Why?
|
| Cerebral Ventricles | 6 | 2004 | 79 | 0.910 |
Why?
|
| Executive Function | 2 | 2016 | 93 | 0.880 |
Why?
|
| Adolescent | 43 | 2020 | 9327 | 0.870 |
Why?
|
| Neural Tube Defects | 6 | 2017 | 45 | 0.840 |
Why?
|
| Intracranial Hypertension | 3 | 2013 | 58 | 0.810 |
Why?
|
| Humans | 115 | 2022 | 89785 | 0.790 |
Why?
|
| Cerebellum | 2 | 2016 | 249 | 0.780 |
Why?
|
| Brain Neoplasms | 6 | 2016 | 783 | 0.760 |
Why?
|
| Cold Temperature | 1 | 2021 | 160 | 0.750 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 201 | 0.740 |
Why?
|
| Intracranial Pressure | 6 | 2022 | 88 | 0.740 |
Why?
|
| Magnetic Resonance Imaging | 25 | 2020 | 3468 | 0.720 |
Why?
|
| Male | 76 | 2021 | 42582 | 0.720 |
Why?
|
| Child, Preschool | 27 | 2021 | 3765 | 0.710 |
Why?
|
| Nerve Growth Factors | 9 | 1996 | 63 | 0.710 |
Why?
|
| Pseudotumor Cerebri | 3 | 2006 | 17 | 0.700 |
Why?
|
| Female | 71 | 2020 | 46494 | 0.690 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 129 | 0.690 |
Why?
|
| Brain | 10 | 2022 | 2303 | 0.680 |
Why?
|
| Dura Mater | 5 | 2020 | 44 | 0.670 |
Why?
|
| Encephalocele | 2 | 2016 | 26 | 0.660 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2016 | 51 | 0.650 |
Why?
|
| Corpus Striatum | 9 | 2007 | 88 | 0.650 |
Why?
|
| Occipital Bone | 2 | 2016 | 18 | 0.620 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 1856 | 0.600 |
Why?
|
| Postoperative Hemorrhage | 1 | 2018 | 46 | 0.590 |
Why?
|
| Mental Disorders | 2 | 2018 | 417 | 0.580 |
Why?
|
| Medulla Oblongata | 1 | 2018 | 93 | 0.570 |
Why?
|
| Epilepsy | 10 | 2011 | 424 | 0.570 |
Why?
|
| Brain Edema | 2 | 2013 | 58 | 0.550 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2016 | 10 | 0.540 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 39 | 0.540 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 155 | 0.540 |
Why?
|
| Electroencephalography | 13 | 2016 | 756 | 0.530 |
Why?
|
| Catheters, Indwelling | 2 | 2018 | 114 | 0.520 |
Why?
|
| Parents | 2 | 2016 | 289 | 0.510 |
Why?
|
| Endoscopy | 4 | 2004 | 352 | 0.510 |
Why?
|
| Radiculopathy | 1 | 2015 | 15 | 0.510 |
Why?
|
| Neurons | 9 | 2010 | 1589 | 0.510 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2015 | 33 | 0.500 |
Why?
|
| Spine | 1 | 2015 | 102 | 0.480 |
Why?
|
| Cranial Fossa, Posterior | 5 | 2020 | 25 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2019 | 2676 | 0.480 |
Why?
|
| Comorbidity | 1 | 2018 | 952 | 0.470 |
Why?
|
| Craniosynostoses | 3 | 2018 | 77 | 0.470 |
Why?
|
| Adult | 36 | 2020 | 26767 | 0.470 |
Why?
|
| Nerve Degeneration | 6 | 2003 | 83 | 0.460 |
Why?
|
| Coma | 2 | 2013 | 47 | 0.460 |
Why?
|
| Infant | 17 | 2020 | 3187 | 0.460 |
Why?
|
| Hematoma, Subdural | 4 | 2002 | 25 | 0.440 |
Why?
|
| Pentobarbital | 1 | 2013 | 20 | 0.440 |
Why?
|
| Pleura | 2 | 2012 | 31 | 0.430 |
Why?
|
| Subdural Space | 3 | 2007 | 17 | 0.420 |
Why?
|
| Neurosurgery | 2 | 2013 | 105 | 0.410 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2013 | 110 | 0.410 |
Why?
|
| Hemangioma, Cavernous | 3 | 1999 | 69 | 0.410 |
Why?
|
| Treatment Outcome | 17 | 2021 | 8243 | 0.400 |
Why?
|
| Neocortex | 5 | 2016 | 96 | 0.390 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 132 | 0.390 |
Why?
|
| Quinolinic Acid | 6 | 2004 | 9 | 0.390 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 480 | 0.390 |
Why?
|
| User-Computer Interface | 1 | 2013 | 187 | 0.390 |
Why?
|
| Touch Perception | 1 | 2013 | 61 | 0.380 |
Why?
|
| Neurologic Examination | 3 | 2010 | 120 | 0.380 |
Why?
|
| Foramen Magnum | 1 | 2011 | 4 | 0.380 |
Why?
|
| Joint Dislocations | 2 | 2010 | 27 | 0.380 |
Why?
|
| Hospitals, Pediatric | 2 | 2010 | 117 | 0.370 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2007 | 1237 | 0.360 |
Why?
|
| Rats | 21 | 2014 | 4048 | 0.360 |
Why?
|
| Retrospective Studies | 17 | 2019 | 9159 | 0.360 |
Why?
|
| Fibroblasts | 7 | 1996 | 759 | 0.360 |
Why?
|
| Temporal Lobe | 4 | 2011 | 176 | 0.360 |
Why?
|
| Epilepsy, Temporal Lobe | 4 | 2011 | 131 | 0.360 |
Why?
|
| Nurse Practitioners | 1 | 2010 | 30 | 0.360 |
Why?
|
| Monitoring, Physiologic | 4 | 2011 | 265 | 0.360 |
Why?
|
| Atlanto-Axial Joint | 1 | 2010 | 9 | 0.350 |
Why?
|
| Computer Simulation | 5 | 2013 | 1101 | 0.350 |
Why?
|
| Spinal Injuries | 1 | 2010 | 23 | 0.350 |
Why?
|
| Temperature | 2 | 2022 | 409 | 0.350 |
Why?
|
| Cerebral Cortex | 6 | 2020 | 591 | 0.350 |
Why?
|
| Shy-Drager Syndrome | 1 | 2009 | 2 | 0.350 |
Why?
|
| Tilt-Table Test | 1 | 2009 | 4 | 0.350 |
Why?
|
| Neurofibromatosis 1 | 2 | 2020 | 39 | 0.340 |
Why?
|
| Cerebrospinal Fluid Pressure | 2 | 2001 | 6 | 0.340 |
Why?
|
| Syncope | 1 | 2009 | 34 | 0.330 |
Why?
|
| Seizures | 3 | 2007 | 308 | 0.330 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2010 | 96 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 6 | 2011 | 511 | 0.330 |
Why?
|
| Pain | 1 | 2012 | 399 | 0.330 |
Why?
|
| Neuroprotective Agents | 3 | 2007 | 100 | 0.320 |
Why?
|
| Headache | 2 | 2011 | 73 | 0.320 |
Why?
|
| Intelligence | 1 | 2008 | 71 | 0.310 |
Why?
|
| Craniocerebral Trauma | 2 | 2013 | 56 | 0.300 |
Why?
|
| Heparin | 2 | 2003 | 185 | 0.300 |
Why?
|
| Electrodes | 2 | 2007 | 88 | 0.290 |
Why?
|
| Brain Mapping | 7 | 2020 | 569 | 0.290 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 3663 | 0.290 |
Why?
|
| Arachnoid Cysts | 1 | 2007 | 3 | 0.280 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2007 | 2 | 0.280 |
Why?
|
| Parietal Bone | 1 | 2007 | 20 | 0.280 |
Why?
|
| Brain Diseases | 3 | 2018 | 187 | 0.280 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 2648 | 0.270 |
Why?
|
| Vagus Nerve | 2 | 2007 | 49 | 0.270 |
Why?
|
| Laparoscopy | 3 | 2012 | 777 | 0.270 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2006 | 5 | 0.270 |
Why?
|
| Young Adult | 10 | 2020 | 6386 | 0.270 |
Why?
|
| Fracture Fixation, Internal | 1 | 2007 | 69 | 0.270 |
Why?
|
| Syringomyelia | 3 | 2011 | 14 | 0.260 |
Why?
|
| Neurilemmoma | 3 | 2011 | 34 | 0.260 |
Why?
|
| Self Care | 1 | 2007 | 166 | 0.250 |
Why?
|
| Electric Stimulation | 6 | 2020 | 365 | 0.250 |
Why?
|
| Cell Death | 5 | 2018 | 261 | 0.250 |
Why?
|
| Deep Brain Stimulation | 1 | 2006 | 63 | 0.250 |
Why?
|
| Equipment Design | 4 | 2016 | 421 | 0.250 |
Why?
|
| Spinal Cord | 2 | 2012 | 255 | 0.250 |
Why?
|
| Middle Aged | 17 | 2020 | 26080 | 0.240 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 32 | 0.240 |
Why?
|
| Pinealoma | 1 | 2004 | 5 | 0.230 |
Why?
|
| Pineal Gland | 1 | 2004 | 15 | 0.230 |
Why?
|
| Central Nervous System Cysts | 1 | 2004 | 9 | 0.230 |
Why?
|
| Language | 2 | 2020 | 156 | 0.230 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2010 | 80 | 0.230 |
Why?
|
| Necrosis | 1 | 2004 | 210 | 0.230 |
Why?
|
| Cohort Studies | 5 | 2020 | 2886 | 0.230 |
Why?
|
| Finite Element Analysis | 3 | 2022 | 78 | 0.230 |
Why?
|
| Nerve Net | 3 | 2020 | 374 | 0.230 |
Why?
|
| Glutamic Acid | 2 | 2004 | 154 | 0.220 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 1729 | 0.220 |
Why?
|
| Dalteparin | 1 | 2003 | 4 | 0.220 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 2003 | 14 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2007 | 2391 | 0.220 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 1729 | 0.210 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2003 | 40 | 0.210 |
Why?
|
| Pericardium | 1 | 2003 | 70 | 0.210 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 1990 | 44 | 0.210 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 4 | 2000 | 12 | 0.200 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 508 | 0.200 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2002 | 2 | 0.200 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2002 | 10 | 0.200 |
Why?
|
| Glutarates | 1 | 2002 | 8 | 0.200 |
Why?
|
| Wound Infection | 1 | 2002 | 17 | 0.200 |
Why?
|
| Brain Injuries | 1 | 2004 | 166 | 0.200 |
Why?
|
| Animals | 32 | 2016 | 27512 | 0.200 |
Why?
|
| Conservative Treatment | 2 | 2020 | 21 | 0.200 |
Why?
|
| Phase Transition | 1 | 2021 | 18 | 0.200 |
Why?
|
| Electric Stimulation Therapy | 1 | 2002 | 47 | 0.190 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 38 | 0.190 |
Why?
|
| Time Factors | 10 | 2013 | 5350 | 0.190 |
Why?
|
| Gallbladder Emptying | 1 | 2001 | 4 | 0.190 |
Why?
|
| Gallbladder | 1 | 2001 | 31 | 0.190 |
Why?
|
| Laminectomy | 3 | 2018 | 28 | 0.190 |
Why?
|
| Jugular Veins | 1 | 2001 | 74 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2010 | 1062 | 0.180 |
Why?
|
| Thermometry | 1 | 2020 | 1 | 0.180 |
Why?
|
| Brachiocephalic Veins | 1 | 2021 | 34 | 0.180 |
Why?
|
| Head Injuries, Closed | 1 | 2000 | 12 | 0.180 |
Why?
|
| Visual Prosthesis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Cerebral Veins | 1 | 2000 | 31 | 0.180 |
Why?
|
| Infant, Premature, Diseases | 1 | 2001 | 77 | 0.180 |
Why?
|
| Spinal Cord Diseases | 1 | 2020 | 29 | 0.170 |
Why?
|
| Parkinson Disease | 1 | 2002 | 150 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2019 | 1255 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2021 | 118 | 0.170 |
Why?
|
| Third Ventricle | 1 | 2020 | 13 | 0.170 |
Why?
|
| Skull Fractures | 1 | 1999 | 25 | 0.170 |
Why?
|
| Neuroendoscopy | 1 | 2020 | 18 | 0.170 |
Why?
|
| Radiography, Interventional | 1 | 2021 | 157 | 0.170 |
Why?
|
| Anticoagulants | 1 | 2003 | 428 | 0.170 |
Why?
|
| Genetic Therapy | 2 | 2002 | 372 | 0.170 |
Why?
|
| Arteriovenous Malformations | 1 | 2000 | 45 | 0.170 |
Why?
|
| Sphenoid Sinus | 1 | 2019 | 7 | 0.170 |
Why?
|
| Hematoma | 1 | 1999 | 108 | 0.160 |
Why?
|
| Movement Disorders | 2 | 2018 | 44 | 0.160 |
Why?
|
| Drug Administration Schedule | 2 | 2013 | 865 | 0.160 |
Why?
|
| RNA, Messenger | 7 | 2018 | 2025 | 0.160 |
Why?
|
| Evoked Potentials | 3 | 2016 | 191 | 0.160 |
Why?
|
| Inflammation | 1 | 2004 | 981 | 0.160 |
Why?
|
| Encephalomalacia | 1 | 2018 | 3 | 0.160 |
Why?
|
| Paresthesia | 1 | 2018 | 15 | 0.150 |
Why?
|
| Central Nervous System Neoplasms | 1 | 1999 | 86 | 0.150 |
Why?
|
| Bone Resorption | 1 | 2018 | 42 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 603 | 0.150 |
Why?
|
| Decompressive Craniectomy | 1 | 2018 | 19 | 0.150 |
Why?
|
| Equipment Failure Analysis | 2 | 2018 | 91 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2018 | 36 | 0.150 |
Why?
|
| Down Syndrome | 1 | 1998 | 55 | 0.150 |
Why?
|
| Spinal Diseases | 1 | 1998 | 44 | 0.150 |
Why?
|
| Cranial Sutures | 1 | 2018 | 47 | 0.150 |
Why?
|
| Cervical Vertebrae | 1 | 1998 | 84 | 0.140 |
Why?
|
| Visual Cortex | 1 | 2020 | 255 | 0.140 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1997 | 14 | 0.140 |
Why?
|
| Hot Temperature | 1 | 2018 | 207 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2018 | 116 | 0.140 |
Why?
|
| N-Methylaspartate | 3 | 2010 | 51 | 0.140 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 21 | 0.140 |
Why?
|
| Skull | 3 | 2005 | 255 | 0.140 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 288 | 0.140 |
Why?
|
| Embolism, Air | 1 | 1996 | 23 | 0.140 |
Why?
|
| Proteome | 1 | 2018 | 135 | 0.140 |
Why?
|
| Reoperation | 5 | 2008 | 604 | 0.140 |
Why?
|
| Length of Stay | 2 | 2013 | 744 | 0.140 |
Why?
|
| Astrocytoma | 1 | 2016 | 82 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2018 | 294 | 0.130 |
Why?
|
| Wireless Technology | 1 | 2016 | 21 | 0.130 |
Why?
|
| Pulmonary Edema | 1 | 1996 | 50 | 0.130 |
Why?
|
| Tectum Mesencephali | 1 | 2016 | 4 | 0.130 |
Why?
|
| Gamma Rhythm | 1 | 2016 | 14 | 0.130 |
Why?
|
| Infant, Newborn | 5 | 2014 | 2498 | 0.130 |
Why?
|
| Corpus Callosum | 2 | 1993 | 59 | 0.130 |
Why?
|
| Glasgow Coma Scale | 2 | 2010 | 74 | 0.130 |
Why?
|
| Patient Satisfaction | 2 | 2010 | 460 | 0.130 |
Why?
|
| Mutism | 1 | 1995 | 1 | 0.130 |
Why?
|
| Dysarthria | 1 | 1995 | 6 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 345 | 0.130 |
Why?
|
| Carotid Artery, Internal | 1 | 1995 | 69 | 0.120 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 2015 | 49 | 0.120 |
Why?
|
| Cerebellar Diseases | 1 | 1995 | 21 | 0.120 |
Why?
|
| Endarterectomy, Carotid | 1 | 1995 | 74 | 0.120 |
Why?
|
| Lipoma | 1 | 1995 | 27 | 0.120 |
Why?
|
| Feasibility Studies | 3 | 2012 | 784 | 0.120 |
Why?
|
| Spinal Neoplasms | 1 | 1995 | 49 | 0.120 |
Why?
|
| Meningomyelocele | 1 | 1995 | 24 | 0.120 |
Why?
|
| Depression | 1 | 2019 | 513 | 0.120 |
Why?
|
| Observer Variation | 2 | 2017 | 614 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1996 | 172 | 0.120 |
Why?
|
| Toxoplasma | 1 | 2015 | 116 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2011 | 202 | 0.120 |
Why?
|
| Catalase | 1 | 1994 | 49 | 0.120 |
Why?
|
| Mitochondria | 2 | 2000 | 555 | 0.120 |
Why?
|
| Radiography | 2 | 2015 | 808 | 0.120 |
Why?
|
| Mandible | 1 | 1995 | 121 | 0.120 |
Why?
|
| Prevalence | 1 | 2018 | 1249 | 0.120 |
Why?
|
| Brain Stem | 1 | 1995 | 167 | 0.120 |
Why?
|
| Diagnosis, Differential | 4 | 2010 | 1607 | 0.120 |
Why?
|
| Motor Cortex | 1 | 2016 | 199 | 0.120 |
Why?
|
| Gene Expression Regulation | 5 | 1990 | 1983 | 0.110 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 45 | 0.110 |
Why?
|
| Patient Care Team | 2 | 2021 | 284 | 0.110 |
Why?
|
| Electric Impedance | 1 | 2014 | 111 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2006 | 278 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 575 | 0.110 |
Why?
|
| Recurrence | 3 | 2008 | 1143 | 0.110 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 2013 | 25 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 1994 | 316 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1993 | 57 | 0.110 |
Why?
|
| Pregnancy | 3 | 2018 | 3040 | 0.110 |
Why?
|
| Hypogastric Plexus | 1 | 2012 | 4 | 0.110 |
Why?
|
| Urodynamics | 1 | 2013 | 123 | 0.110 |
Why?
|
| Huntington Disease | 1 | 1993 | 39 | 0.110 |
Why?
|
| Urinary Retention | 1 | 2012 | 42 | 0.100 |
Why?
|
| Mental Processes | 1 | 2012 | 31 | 0.100 |
Why?
|
| Patient Admission | 1 | 2013 | 114 | 0.100 |
Why?
|
| Replantation | 1 | 2012 | 36 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2007 | 458 | 0.100 |
Why?
|
| Syndrome | 2 | 2004 | 450 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2013 | 82 | 0.100 |
Why?
|
| Arachnoiditis | 1 | 2012 | 2 | 0.100 |
Why?
|
| Action Potentials | 3 | 2010 | 600 | 0.100 |
Why?
|
| Head | 1 | 2013 | 137 | 0.100 |
Why?
|
| Child Behavior | 1 | 2012 | 47 | 0.100 |
Why?
|
| Central Nervous System Diseases | 1 | 1992 | 52 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 109 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2017 | 899 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2007 | 1350 | 0.100 |
Why?
|
| Ureter | 1 | 2012 | 95 | 0.100 |
Why?
|
| Cicatrix | 1 | 2012 | 68 | 0.100 |
Why?
|
| Surgical Flaps | 1 | 2014 | 250 | 0.090 |
Why?
|
| Thromboembolism | 1 | 1992 | 119 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 1993 | 232 | 0.090 |
Why?
|
| Lumbosacral Region | 2 | 2002 | 27 | 0.090 |
Why?
|
| Lumbosacral Plexus | 1 | 2011 | 9 | 0.090 |
Why?
|
| Spinal Nerve Roots | 1 | 2011 | 17 | 0.090 |
Why?
|
| Facial Pain | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cell Survival | 4 | 2007 | 983 | 0.090 |
Why?
|
| Neural Pathways | 2 | 2010 | 319 | 0.090 |
Why?
|
| Age Factors | 2 | 2008 | 1879 | 0.090 |
Why?
|
| Endocrine System Diseases | 1 | 2011 | 23 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2011 | 45 | 0.090 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 44 | 0.090 |
Why?
|
| Delta Rhythm | 1 | 2011 | 19 | 0.090 |
Why?
|
| Morphine | 1 | 2012 | 130 | 0.090 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 48 | 0.090 |
Why?
|
| Biological Clocks | 2 | 2010 | 74 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1864 | 0.090 |
Why?
|
| Genotype | 1 | 2015 | 1853 | 0.090 |
Why?
|
| In Vitro Techniques | 4 | 2016 | 996 | 0.090 |
Why?
|
| Vision Disorders | 1 | 2011 | 75 | 0.090 |
Why?
|
| Oligodendroglia | 1 | 2011 | 124 | 0.090 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 81 | 0.090 |
Why?
|
| Aged | 8 | 2020 | 19212 | 0.090 |
Why?
|
| Otolaryngology | 1 | 2011 | 55 | 0.090 |
Why?
|
| Ligaments, Articular | 1 | 2010 | 38 | 0.090 |
Why?
|
| Facial Bones | 1 | 1990 | 37 | 0.090 |
Why?
|
| Placenta | 2 | 1988 | 181 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2010 | 281 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 177 | 0.080 |
Why?
|
| Robotics | 1 | 2012 | 270 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2010 | 86 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 179 | 0.080 |
Why?
|
| Genetic Vectors | 4 | 2002 | 446 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2012 | 228 | 0.080 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 98 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 5 | 1996 | 27 | 0.080 |
Why?
|
| Posture | 2 | 2000 | 125 | 0.080 |
Why?
|
| Wechsler Scales | 1 | 2008 | 21 | 0.080 |
Why?
|
| Injections, Subcutaneous | 2 | 2003 | 122 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 1799 | 0.080 |
Why?
|
| Lipid Peroxidation | 2 | 2007 | 45 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2007 | 1929 | 0.080 |
Why?
|
| Chicago | 1 | 2013 | 1431 | 0.080 |
Why?
|
| Cervical Plexus | 1 | 2007 | 4 | 0.080 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2007 | 12 | 0.080 |
Why?
|
| Esophageal Sphincter, Upper | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cognition | 1 | 2012 | 579 | 0.070 |
Why?
|
| Speech | 1 | 2008 | 85 | 0.070 |
Why?
|
| Speech Perception | 1 | 2008 | 72 | 0.070 |
Why?
|
| Health Priorities | 1 | 2007 | 22 | 0.070 |
Why?
|
| Esophageal Diseases | 1 | 2007 | 27 | 0.070 |
Why?
|
| Frontal Lobe | 1 | 2008 | 132 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 3 | 2016 | 396 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2765 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 451 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2011 | 677 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2020 | 4320 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2010 | 387 | 0.070 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 19 | 0.070 |
Why?
|
| Synaptic Membranes | 1 | 2007 | 14 | 0.070 |
Why?
|
| Bone Wires | 1 | 2007 | 13 | 0.070 |
Why?
|
| Home Nursing | 1 | 2007 | 19 | 0.070 |
Why?
|
| Substantia Nigra | 3 | 1996 | 28 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 114 | 0.070 |
Why?
|
| Receptors, Dopamine | 3 | 2000 | 37 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 4 | 1994 | 44 | 0.070 |
Why?
|
| Prosthesis-Related Infections | 1 | 2007 | 61 | 0.070 |
Why?
|
| Microelectrodes | 2 | 2016 | 83 | 0.070 |
Why?
|
| Back Pain | 2 | 2011 | 43 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 476 | 0.070 |
Why?
|
| Prothrombin Time | 1 | 2006 | 22 | 0.070 |
Why?
|
| Preoperative Care | 3 | 2017 | 395 | 0.070 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2006 | 24 | 0.060 |
Why?
|
| Cell Line | 4 | 1994 | 2495 | 0.060 |
Why?
|
| Data Collection | 1 | 2007 | 377 | 0.060 |
Why?
|
| Genetic Engineering | 3 | 1996 | 115 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 1994 | 87 | 0.060 |
Why?
|
| Fever | 1 | 2006 | 127 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2004 | 17 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2003 | 1704 | 0.060 |
Why?
|
| Injections, Spinal | 1 | 2004 | 45 | 0.060 |
Why?
|
| Membrane Glycoproteins | 2 | 1986 | 431 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1532 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 715 | 0.060 |
Why?
|
| Receptors, Glutamate | 2 | 1994 | 24 | 0.060 |
Why?
|
| Astrocytes | 2 | 1995 | 142 | 0.060 |
Why?
|
| Algorithms | 3 | 2007 | 1904 | 0.060 |
Why?
|
| Epilepsy, Absence | 1 | 2003 | 10 | 0.060 |
Why?
|
| Brain Tissue Transplantation | 2 | 1993 | 5 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2003 | 46 | 0.050 |
Why?
|
| Dominance, Cerebral | 2 | 2011 | 66 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2007 | 403 | 0.050 |
Why?
|
| Transfection | 3 | 1994 | 909 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 74 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 272 | 0.050 |
Why?
|
| Scoliosis | 2 | 2000 | 32 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2011 | 2887 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 378 | 0.050 |
Why?
|
| Pressure | 1 | 2003 | 166 | 0.050 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2010 | 41 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2002 | 1 | 0.050 |
Why?
|
| Peritoneal Cavity | 1 | 2002 | 21 | 0.050 |
Why?
|
| Peritoneum | 1 | 2002 | 57 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2003 | 130 | 0.050 |
Why?
|
| Heat-Shock Proteins | 2 | 1993 | 183 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 368 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2002 | 112 | 0.050 |
Why?
|
| Motor Activity | 3 | 2016 | 327 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 1983 | 269 | 0.050 |
Why?
|
| Base Sequence | 4 | 1994 | 2329 | 0.050 |
Why?
|
| Macrophages | 1 | 2004 | 581 | 0.050 |
Why?
|
| Postprandial Period | 1 | 2001 | 47 | 0.050 |
Why?
|
| Phosphenes | 1 | 2020 | 5 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 1983 | 334 | 0.050 |
Why?
|
| NADH Dehydrogenase | 1 | 2000 | 22 | 0.050 |
Why?
|
| Herbicides | 1 | 2000 | 36 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 995 | 0.040 |
Why?
|
| Piperazines | 2 | 2010 | 283 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2000 | 57 | 0.040 |
Why?
|
| Electrocorticography | 1 | 2020 | 45 | 0.040 |
Why?
|
| Hypesthesia | 1 | 2000 | 15 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2020 | 55 | 0.040 |
Why?
|
| Biopsy | 1 | 2004 | 1184 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1994 | 3024 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 222 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2583 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 2000 | 270 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 798 | 0.040 |
Why?
|
| Foot | 1 | 2000 | 52 | 0.040 |
Why?
|
| Stereotaxic Techniques | 2 | 1997 | 80 | 0.040 |
Why?
|
| Pediatrics | 1 | 2004 | 359 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2000 | 490 | 0.040 |
Why?
|
| Dopamine | 3 | 1996 | 276 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2001 | 231 | 0.040 |
Why?
|
| Models, Biological | 2 | 2018 | 1765 | 0.040 |
Why?
|
| Electrophysiology | 2 | 2012 | 403 | 0.040 |
Why?
|
| Cysts | 1 | 1999 | 106 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2000 | 477 | 0.040 |
Why?
|
| Supination | 1 | 1998 | 6 | 0.040 |
Why?
|
| Collagen Type VI | 1 | 2018 | 5 | 0.040 |
Why?
|
| Retroviridae | 2 | 1995 | 79 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1997 | 29 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1717 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2000 | 493 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2018 | 123 | 0.040 |
Why?
|
| Rotation | 2 | 2014 | 91 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 104 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 127 | 0.040 |
Why?
|
| Arthrodesis | 1 | 1997 | 26 | 0.040 |
Why?
|
| Prone Position | 1 | 2017 | 57 | 0.040 |
Why?
|
| Acetylcholinesterase | 2 | 1994 | 48 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 315 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 283 | 0.030 |
Why?
|
| Nerve Fibers | 2 | 1995 | 48 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 1996 | 37 | 0.030 |
Why?
|
| Emergencies | 1 | 1997 | 122 | 0.030 |
Why?
|
| Macaca | 1 | 2016 | 89 | 0.030 |
Why?
|
| Meningioma | 1 | 1996 | 62 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 1996 | 66 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 1997 | 164 | 0.030 |
Why?
|
| Circadian Rhythm | 3 | 1989 | 303 | 0.030 |
Why?
|
| Proteomics | 1 | 2018 | 232 | 0.030 |
Why?
|
| Serogroup | 1 | 2015 | 9 | 0.030 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1995 | 4 | 0.030 |
Why?
|
| Myelography | 1 | 1995 | 11 | 0.030 |
Why?
|
| S100 Proteins | 2 | 1994 | 52 | 0.030 |
Why?
|
| Patient Selection | 1 | 1999 | 678 | 0.030 |
Why?
|
| Pons | 1 | 1995 | 25 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 1997 | 258 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 277 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 726 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1997 | 306 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1995 | 160 | 0.030 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1994 | 8 | 0.030 |
Why?
|
| Monoamine Oxidase | 1 | 1994 | 25 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 39 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1996 | 258 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 1994 | 282 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1994 | 47 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1994 | 88 | 0.030 |
Why?
|
| Quality of Life | 1 | 2003 | 1674 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1214 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 435 | 0.030 |
Why?
|
| Methylprednisolone Hemisuccinate | 1 | 1994 | 10 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 1994 | 16 | 0.030 |
Why?
|
| Putamen | 1 | 1994 | 13 | 0.030 |
Why?
|
| Chromans | 1 | 1994 | 29 | 0.030 |
Why?
|
| Prognosis | 2 | 2015 | 3785 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1993 | 72 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 1994 | 59 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1994 | 102 | 0.030 |
Why?
|
| Nitro Compounds | 1 | 1993 | 2 | 0.030 |
Why?
|
| Glycoproteins | 2 | 1986 | 235 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 1994 | 71 | 0.030 |
Why?
|
| Propionates | 1 | 1993 | 33 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1993 | 49 | 0.030 |
Why?
|
| Eosinophilia | 1 | 1994 | 84 | 0.030 |
Why?
|
| Organ Specificity | 2 | 1993 | 277 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 298 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1993 | 153 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1993 | 177 | 0.030 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2012 | 28 | 0.030 |
Why?
|
| Simplexvirus | 1 | 1993 | 151 | 0.030 |
Why?
|
| Genes | 2 | 1990 | 306 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1992 | 25 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1997 | 607 | 0.030 |
Why?
|
| Mice | 5 | 2011 | 11846 | 0.030 |
Why?
|
| Bandages | 1 | 1992 | 42 | 0.030 |
Why?
|
| Reticulin | 1 | 1992 | 4 | 0.030 |
Why?
|
| Vimentin | 1 | 1992 | 46 | 0.020 |
Why?
|
| Ion Channels | 1 | 1993 | 246 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 243 | 0.020 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2011 | 5 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 511 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1992 | 197 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 36 | 0.020 |
Why?
|
| Dexamethasone | 2 | 1990 | 343 | 0.020 |
Why?
|
| Bicuculline | 1 | 2010 | 18 | 0.020 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2010 | 15 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2010 | 50 | 0.020 |
Why?
|
| Glucose | 1 | 1994 | 629 | 0.020 |
Why?
|
| Flavoproteins | 1 | 2010 | 25 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2018 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2012 | 248 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 1997 | 1052 | 0.020 |
Why?
|
| Biophysics | 1 | 2010 | 153 | 0.020 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2011 | 69 | 0.020 |
Why?
|
| Constipation | 1 | 2011 | 64 | 0.020 |
Why?
|
| Hypophysectomy | 1 | 1990 | 27 | 0.020 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1990 | 8 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 244 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 77 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1993 | 961 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1994 | 731 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2010 | 77 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1990 | 45 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 312 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 871 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 6778 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 1990 | 1158 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 524 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1990 | 277 | 0.020 |
Why?
|
| Hippocampus | 1 | 1993 | 449 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 1990 | 119 | 0.020 |
Why?
|
| Reference Values | 1 | 1990 | 662 | 0.020 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1988 | 6 | 0.020 |
Why?
|
| Poly A | 1 | 1988 | 23 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1988 | 44 | 0.020 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1988 | 18 | 0.020 |
Why?
|
| Language Tests | 1 | 2008 | 37 | 0.020 |
Why?
|
| Vocal Cord Paralysis | 1 | 2007 | 27 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5539 | 0.020 |
Why?
|
| Carbohydrate Sequence | 2 | 1986 | 20 | 0.020 |
Why?
|
| Video Recording | 1 | 2008 | 203 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 559 | 0.020 |
Why?
|
| Gestational Age | 1 | 1988 | 329 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 3402 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 119 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 727 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2006 | 50 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1989 | 328 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1988 | 357 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2006 | 92 | 0.020 |
Why?
|
| ROC Curve | 1 | 2008 | 776 | 0.020 |
Why?
|
| Neostriatum | 2 | 1996 | 26 | 0.020 |
Why?
|
| Apomorphine | 2 | 1995 | 10 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2005 | 144 | 0.020 |
Why?
|
| Communication | 1 | 2008 | 461 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 1985 | 105 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1992 | 1542 | 0.010 |
Why?
|
| Scalp | 1 | 2003 | 72 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 2003 | 73 | 0.010 |
Why?
|
| DNA, Complementary | 2 | 1994 | 391 | 0.010 |
Why?
|
| Animal Population Groups | 1 | 1983 | 2 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1986 | 538 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1983 | 71 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 305 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2011 | 1665 | 0.010 |
Why?
|
| Karyotyping | 1 | 1983 | 253 | 0.010 |
Why?
|
| Ascites | 1 | 1983 | 56 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2006 | 575 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1983 | 397 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 591 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2005 | 411 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 1994 | 303 | 0.010 |
Why?
|
| Rotenone | 1 | 2000 | 18 | 0.010 |
Why?
|
| Spinal Cord Compression | 1 | 2000 | 29 | 0.010 |
Why?
|
| Superoxides | 1 | 2000 | 74 | 0.010 |
Why?
|
| Glutathione | 1 | 2000 | 108 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2000 | 436 | 0.010 |
Why?
|
| Behavior, Animal | 2 | 1994 | 380 | 0.010 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 1 | 1997 | 4 | 0.010 |
Why?
|
| Boston | 1 | 1997 | 37 | 0.010 |
Why?
|
| Cost Control | 1 | 1997 | 45 | 0.010 |
Why?
|
| Kyphosis | 1 | 1997 | 14 | 0.010 |
Why?
|
| Saimiri | 2 | 1989 | 50 | 0.010 |
Why?
|
| Body Temperature | 2 | 1989 | 125 | 0.010 |
Why?
|
| Microinjections | 1 | 1996 | 71 | 0.010 |
Why?
|
| Cues | 2 | 1989 | 174 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1995 | 154 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1994 | 12 | 0.010 |
Why?
|
| Amphetamine | 1 | 1995 | 103 | 0.010 |
Why?
|
| Nerve Endings | 1 | 1994 | 16 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1994 | 108 | 0.010 |
Why?
|
| Enkephalins | 1 | 1993 | 16 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 1993 | 30 | 0.010 |
Why?
|
| Glutamates | 1 | 1994 | 88 | 0.010 |
Why?
|
| Vero Cells | 1 | 1993 | 103 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1993 | 51 | 0.010 |
Why?
|
| Eosinophils | 1 | 1994 | 194 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 313 | 0.010 |
Why?
|
| Ubiquitins | 1 | 1993 | 38 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1993 | 68 | 0.010 |
Why?
|
| Disease Progression | 1 | 1997 | 1466 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 543 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 919 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1994 | 466 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 1576 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1990 | 22 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1994 | 954 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 155 | 0.010 |
Why?
|
| Colforsin | 1 | 1990 | 74 | 0.010 |
Why?
|
| Drinking | 1 | 1989 | 33 | 0.010 |
Why?
|
| Ribonuclease H | 1 | 1988 | 8 | 0.000 |
Why?
|
| Nucleic Acid Conformation | 1 | 1990 | 346 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1988 | 130 | 0.000 |
Why?
|
| Trophoblasts | 1 | 1988 | 33 | 0.000 |
Why?
|
| Endoribonucleases | 1 | 1988 | 94 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1994 | 3250 | 0.000 |
Why?
|
| Amino Sugars | 1 | 1986 | 3 | 0.000 |
Why?
|
| Mannose | 1 | 1986 | 9 | 0.000 |
Why?
|
| Biomarkers | 1 | 1993 | 1773 | 0.000 |
Why?
|
| Learning | 1 | 1989 | 286 | 0.000 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1986 | 127 | 0.000 |
Why?
|
| DNA | 1 | 1990 | 1311 | 0.000 |
Why?
|